Correlation Between Oncologix Tech and TransAKT

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncologix Tech and TransAKT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncologix Tech and TransAKT into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncologix Tech and TransAKT, you can compare the effects of market volatilities on Oncologix Tech and TransAKT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncologix Tech with a short position of TransAKT. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncologix Tech and TransAKT.

Diversification Opportunities for Oncologix Tech and TransAKT

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Oncologix and TransAKT is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncologix Tech and TransAKT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TransAKT and Oncologix Tech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncologix Tech are associated (or correlated) with TransAKT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TransAKT has no effect on the direction of Oncologix Tech i.e., Oncologix Tech and TransAKT go up and down completely randomly.

Pair Corralation between Oncologix Tech and TransAKT

Given the investment horizon of 90 days Oncologix Tech is expected to generate 22.27 times less return on investment than TransAKT. But when comparing it to its historical volatility, Oncologix Tech is 6.41 times less risky than TransAKT. It trades about 0.03 of its potential returns per unit of risk. TransAKT is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  2.50  in TransAKT on October 21, 2024 and sell it today you would lose (2.23) from holding TransAKT or give up 89.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Oncologix Tech  vs.  TransAKT

 Performance 
       Timeline  
Oncologix Tech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncologix Tech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Oncologix Tech is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
TransAKT 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TransAKT are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent forward-looking signals, TransAKT exhibited solid returns over the last few months and may actually be approaching a breakup point.

Oncologix Tech and TransAKT Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncologix Tech and TransAKT

The main advantage of trading using opposite Oncologix Tech and TransAKT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncologix Tech position performs unexpectedly, TransAKT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TransAKT will offset losses from the drop in TransAKT's long position.
The idea behind Oncologix Tech and TransAKT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Insider Screener
Find insiders across different sectors to evaluate their impact on performance